產品優勢
Stemgent 產品幫助幹細胞生長
高純度，批號間差異低，全球使用
Stemolecule (Small Molecules)
請左右移動表格位置查看更完整內容
| 產品貨號 | 產品名稱 | 產品描述 | 包裝大小 |
|---|---|---|---|
| 04-0004 | CHIR99021 | The most selective inhibitor of glycogen synthase kinase 3β (GSK-3β) reported to date | 2 mg |
| 04-0004-02 | 2 mg (10 mM sol.) | ||
| 04-0004-10 | 10 mg | ||
| 04-0005 | Stemolecule Sodium Butyrate | 500 mg | |
| 04-0006 | PD0325901 | A small molecule targeting mitogen- activated protein kinase (MAPK/ERK kinase or MEK) with potential antineoplastic activity | 2 mg |
| 04-0006-02 | 2 mg (10 mM sol.) | ||
| 04-0006-10 | 10 mg | ||
| 04-0034 | Wnt Inhibitor IWP-2 | An antagonist of the Wnt/β- catenin pathway | 2 mg |
| 04-0035 | Wnt Inhibitor IWP-3 | An antagonist of the Wnt/β- catenin pathway | 2 mg |
| 04-0036 | Wnt Inhibitor IWP-4 | An antagonist of the Wnt/β- catenin pathway | 2 mg |
| 04-0036-50 | 50 mg | ||
| 04-0046 | XAV939 | A cell- permeable small molecule inhibitor of the Wnt/β-catenin pathway | 2 mg |
| 04-0074 | LDN-193189 | A cell permeable small molecule inhibitor of bone morphogenetic protein (BMP) type Ⅰ receptor ALK2 and ALK3 (IC50= 5nM and 30nM respectively) | 2 mg |
| 04-0074-02 | 2 mg (10 mM sol.) | ||
| 04-0074-10 | 10 mg | ||
| 04-0079 | Stemolecule WH-4-023 | 2 mg | |
| 04-0080 | Stemolecule SB590885 | 2 mg | |
| 04-0081 | Stemolecule IM-12 | 2 mg |
Stemfactor / Cytokine
請左右移動表格位置查看更完整內容
| 產品貨號 | 產品名稱 | 包裝大小 |
|---|---|---|
| 03-0001 | Activin A, Human Recombinant | 5 μg |
| 03-0002 | FGF-basic, Human Recombinant | 50 μg |
| 03-0007 | BMP-4, Human Recombinant | 10 μg |
| 03-0011 | LIF, Mouse Recombinant | 1 ml, 10 μg/ml |
| 03-0011-100 | 1 ml, 100 μg/ml | |
| 03-0016 | LIF, Human Recombinant | 1 ml, 10 μg/ml |
| 03-0016-100 | 1 ml, 100 μg/ml | |
| 03-0017 | B18R Recombinant Protein, Carrier-free | 50 μg |
| 03-0019 | Hepatocyte Growth Factor, Human Recombinant | 25 μg |
| 03-0019-250 | 250 μg |
Stemolecule (Small Molecules) Others
請左右移動表格位置查看更完整內容
| 產品貨號 | 產品名稱 | 產品描述 | 包裝大小 |
|---|---|---|---|
| 04-0001 | RG108 | A cell-permeablesmall molecule that inhibits DNA methyltransferases | 10 mg |
| 04-0002 | BIX01294 | A histone lysine methyltransferase (HMTase) inhibitor that selectively inhibits the G9a HMTase and the generation of histone H3 lysine 9 methylation (H3K9me2) | 5 mg |
| 04-0003 | BIO(6-bromoindirubin- 3′-oxime) | A potent, reversible and ATP-competitive inhibitor for GSK-3α/β in the Wnt signaling pathway | 2 mg |
| 04-0007 | Valproic Acid | A histone deacetylase (HDAC) inhibitor which improves reprogramming efficiency by at least 100 fold | 5 g |
| 04-0009 | Purmorphamine | A small molecule that promotes the differentiation of human and murine mesenchymal progenitor cells into osteoblasts | 5 mg |
| 04-0010 | SB431542 | An inhibitor of the transforming growth factor-beta 1 (TGF-β1) activin receptor-like kinases (ALKs) | 5 mg |
| 04-0010-05 | 5 mg (10 mMsol.) | ||
| 04-0010-10 | 10 mg | ||
| 04-0012 | Y27632 | A cell-permeable small molecule Rho-associated kinase (ROCK) inhibitor | 2 mg |
| 04-0012-10 | 10 mg | ||
| 04-0012-02 | Y27632 in Solution | A cell-permeable small molecule Rho-associated kinase (ROCK) inhibitor | 2 mg |
| 04-0012-H-10 | Y27632 Dihydrochloride Hydrate | A cell-permeable small molecule Rho-associated kinase (ROCK) inhibitor | 10 mg |
| 04-0014 | A83-01 | A selective inhibitor of the transforming growth factor-beta (TGF-β) type I receptor ALK5, the Activin/Nodal receptor ALK4, and the nodal receptor ALK7 | 2 mg |
| 04-0014-10 | 10 mg | ||
| 04-0015 | ALK5 Inhibitor | A selective and ATP-competitive inhibitor of the TGF-β family type I receptor activin receptor- like kinase (ALK5) | 1 mg |
| 04-0016 | Doxycycline hyclate (Dox) | A broad spectrum antibiotic derivative of tetracycline and an inhibitor of matrix metalloproteinases | 10 mg |
| 04-0017 | Thiazovivin | A selective, cell permeable small molecule that directly targets Rho-associated kinase (ROCK) | 1 mg |
| 04-0021 | All-Trans Retinoic Acid | An oxidized form of Vitamin A and functions as a signaling molecule for various developmental pathways that control differentiation and proliferation | 100 mg |
| 04-0022 | Cyclopamine | A steroid alkaloid isolated from the corn lily (Veratrum californicum) and originally identified as a teratogenic agent | 2 mg |
| 04-0024 | Dorsomorphin | A potent inhibitor of AMP-activated protein kinase (AMPK) (Ki=109nM) and bone morphogenic protein (BMP) signaling | 2 mg |
| 04-0025 | Forskolin | A natural compound produced by the Indian Coleus plant (Coleus forskohlii) | 10 mg |
| 04-0028 | KAAD-Cyclopamine | A sonic hedgehog antagonist known to target Smoothened | 100 μg |
| 04-0041 | DAPT | A cell-permeable dipeptide, inhibits γ-secretase and indirectly inhibits Notch, a γ-secretase substrate | 5 mg |
| 04-0054 | LY411575 | A selective, cell permeable, small molecule gamma secretase inhibitor which blocks Notch activation | 5 mg |
| SRP002 | ec23® (ATRA Alt.) | a stable synthetic retinoid based on all-trans retinoic acid (ATRA) | 5 mg |
| SRP002-2 | 5 mg×2 |
Reference of Top Selling Stemolecule
- Attari F, et al. (2014) Efficient induction of pluripotency in primordial germ cells by dual inhibition of TGF-β and ERK signaling pathways. Stem Cells Dev. 23(10):1050-61.
- Li, W, et al. (2014) Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2. Stem Cells. 27:2992-3000.
- Itokazu T, et al. (2014) Involvement of Wnt/β-catenin signaling in the development of neuropathic pain. Neurosci Res. 79:34-40.
- Blaschke K, et al. (2013) Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature. 500(7461):222-6.
- Sundberg M, et al. (2013) Improved cell therapy protocols for Parkinson’s disease based on differentiation efficiency and safety of hESC-, hiPSC-, and non-human primate iPSC-derived dopaminergic neurons. Stem Cells. 31(8):1548-62.
- Koehler KR, et al. (2013) Generation of inner ear sensory epithelia from pluripotent stem cells in 3D culture. Nature. 500(7461):217-21.
- Uyama M, et al. (2013) Wasf2: A novel target of intermittent parathyroid hormone administration. Int J Mol Med. 31(5):1243-7.
- Chesebro JE, et al. (2013) Interplay between a Wnt-dependent organiser and the Notch segmentation clock regulates posterior development in Periplaneta americana. Biol Open. 2(2):227-37.
- Kinney MA, et al. (2013) Temporal modulation of β-catenin signaling by multicellular aggregation kinetics impacts embryonic stem cell cardiomyogenesis. Stem Cells Dev. 22(19):2665-77.
- Rezania A. et al. (2013) Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo. Stem Cells. 31(11):2432-42.
- Chien Y, et al. (2012) Corneal repair by human corneal keratocyte-reprogrammed iPSCs and amphiphatic carboxymethyl-hexanoyl chitosan hydrogel. Biomaterials. 33(32):8003-16.
- Farin HF, et al. (2012) Redundant Sources of Wnt Regulate Intestinal Stem Cells and Promote Formation of Paneth Cells. Gastroenterology. 143(6):1518-1529.e7.
- Hudson J, et al. (2012) Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev. 21(9):1513-23.
- Nagy K, et al. (2011) Induced pluripotent stem cell lines derived from equine fibroblasts. Stem Cell Rev. 7(3):693-702.
- Wang B, et al. (2011) Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages. PLoS Curr. 3:RRN1274.
世翔國際有限公司